Clinical trial
Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis (ADJUVITE)
The primary objective is to demonstrate a higher response rate at 2 months in the adalimumab arm versus the placebo arm.
| Category | Value |
|---|---|
| Study start date | 2011-05-24 |